| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.9M | — | +15.1% |
| Cost of Revenue | $3.7M | — | +16.1% |
| Gross Profit | $13.2M | — | +14.8% |
| R&D Expense | $241K | — | +45.2% |
| SG&A Expense | $10.3M | — | +9.6% |
| Operating Income | $2.7M | — | +37.8% |
| Pre-tax Income | $2.8M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.1M | -7.7% | +1.8% |
| Accounts Receivable | $24.8M | +0.4% | +10.7% |
| Inventory | $3.8M | +14.3% | +9.8% |
| Current Assets | $44.6M | -1.2% | +8.7% |
| Total Assets | $53.6M | -0.3% | +9.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $169K | — | -92.7% |
| Capital Expenditures | $252K | — | +581.1% |
| Investing Cash Flow | -$267K | — | -360.3% |
| Financing Cash Flow | -$1.1M | — | +75.9% |
| Free Cash Flow | -$83K | — | -103.7% |
| +31.5% |
| Income Tax | $668K | — | +1.4% |
| Net Income | $2.1M | — | +44.9% |
| EPS (Basic) | $0.26 | — | +52.9% |
| EPS (Diluted) | $0.25 | — | +56.3% |
| $8.8M |
| -16.3% |
| +18.1% |
| Total Liabilities | $8.9M | -16.3% | +19.4% |
| Stockholders' Equity | $44.7M | +3.6% | +7.9% |